TRUMF News and Press, Terumo Corp.

2024-06-21 17:01:54 ET Summary Artivion, Inc. has continued to log double-digit revenue growth with contributions from diverse assets including its stent grafts, heart valves, and cryopreserved tissue grafts. Positive post-approval trial data for the On-X aortic valve and a succes...

2024-06-21 15:50:11 ET Summary Haemonetics faces near-term revenue growth challenges due to the loss of its plasma collections business with CSL over the next two years. Management has used M&A to boost its revenue growth, including the very successful deal for Cardiva to ente...

2024-05-16 13:41:05 ET Terumo Corporation (TRUMY) Q4 2024 Results Conference Call May 14, 2024 4:30 AM ET Company Participants Jin Hagimoto - CFO Hikaru Samejima - President, CEO & Director Presentation Jin Hagimoto I'm Hagimoto, Terumo's CFO....

2024-02-08 19:55:03 ET Terumo Corporation (TRUMF) Q3 2024 Earnings Conference Call February 07, 2024 2:45 AM ET Company Participants Naoki Muto – Chief Financial Officer Conference Call Participants Presentation Naoki Muto Hello. I am t...

2024-02-08 10:05:00 ET More on Terumo Improved Revenue Growth Is Terumo's Next Major Target Historical earnings data for Terumo Dividend scorecard for Terumo Read the full article on Seeking Alpha For further details see: Terumo says revenue for n...

2024-01-17 07:12:44 ET Summary Terumo has benefited from improved sentiment in the med-tech sector, as well as its own margin-focused financial outperformance. The company absorbed some revenue headwinds from divestments and weaker glucose monitoring, but core cardiovascular and v...

2023-11-17 15:27:06 ET Terumo Corporation (TRUMF) Q2 2024 Earnings Conference Call November 15, 2023 06:00 ET Company Participants Naoki Muto - Chief Accounting Officer & Chief Financial Officer Shinjiro Sato - Chief Executive Officer Conference Call Partic...

2023-10-13 16:37:00 ET Summary Haemonetics has outperformed the medical device sector, with shares up 7% on very strong revenue growth in plasma collection and good margin leverage. The recent acquisition of OpSens expands Haemonetics' Hospital product portfolio; a specialty guide...

2023-10-13 14:37:09 ET Summary Artivion has used M&A to reposition itself towards growth opportunities in aortic disease care and heart valves. The company's legacy operations contribute positively to revenue and margins but have limited growth prospects. The success of Ar...

2023-09-08 07:25:58 ET Summary Terumo's recent performance has been mixed, with operating income misses and lower guidance tied in large part to inflationary cost pressures. Management is looking to price hikes and operational efficiency efforts, including relocating manufacturing...